Loading...
Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG
Haggag, Y.A. Abdel-Wahab, Y. Ojo, O. Osman, M.A. El-Gizawy, S. El-Tanani, Mohamed Faheem, A. McCarron, P.A.
Haggag, Y.A.
Abdel-Wahab, Y.
Ojo, O.
Osman, M.A.
El-Gizawy, S.
El-Tanani, Mohamed
Faheem, A.
McCarron, P.A.
Publication Date
2016-02-29
End of Embargo
Supervisor
Rights
© 2016 Elsevier B.V. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2015-12-26
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
The aim of this study was to design a controlled release vehicle for insulin to preserve its stability and biological activity during fabrication and release. A modified, double emulsion, solvent evaporation, technique using homogenisation force optimised entrapment efficiency of insulin into biodegradable nanoparticles (NP) prepared from poly (dl-lactic-co-glycolic acid) (PLGA) and its PEGylated diblock copolymers. Formulation parameters (type of polymer and its concentration, stabiliser concentration and volume of internal aqueous phase) and physicochemical characteristics (size, zeta potential, encapsulation efficiency, in vitro release profiles and in vitro stability) were investigated. In vivo insulin sensitivity was tested by diet-induced type II diabetic mice. Bioactivity of insulin was studied using Swiss TO mice with streptozotocin-induced type I diabetic profile. Insulin-loaded NP were spherical and negatively charged with an average diameter of 200–400 nm. Insulin encapsulation efficiency increased significantly with increasing ratio of co-polymeric PEG. The internal aqueous phase volume had a significant impact on encapsulation efficiency, initial burst release and NP size. Optimised insulin NP formulated from 10% PEG–PLGA retained insulin integrity in vitro, insulin sensitivity in vivo and induced a sustained hypoglycaemic effect from 3 h to 6 days in type I diabetic mice.
Version
Accepted manuscript
Citation
Haggag Y, Abdel-Wahab Y, Ojo O et al. (2016) Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG. International Journal of Pharmaceutics. 499(1-2): 236-246.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article